MENU

Celgene Aktie (NASDAQ:CELG)

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.

{{ formattedPrice }} {{ change }} (-2,34 %)

Quotes delayed. Last trade: 22-10-2018, 05:15:19pm CEST

CELG vs. S&P 500
Eröffnung {{ openPrice }} Schlusskurs {{ closePrice }}
Tages-Hoch {{ high }} Tages-Tief {{ low }}
Geld {{ bid }} Brief {{ ask }}
Volumen 929639    

Related Articles